Become a Member

Track your favourite stocks
Create & monitor portfolios
Daily portfolio value

Company	Chg	Chg %
Quickpicks
£	%
Add shares to your quickpicks to display them here!

Rtw Biotech (RTW) Share News

RTW Biotech NAV rises 15% as public investments drive returns

14th Sep 2026 11:49

(Alliance News) - RTW Biotech Opportunities Ltd on Monday reported a positive net asset value return for the first half of 2026, supported by improving biotechnology sector sentiment, M&A activity and clinical progress across its portfolio. Read More

RTW Biotech notes further investment in investee Encoded Therapeutics

11th Sep 2026 10:46

(Alliance News) - RTW Biotech Opportunities Ltd on Friday said there was an additional investment in the financing of private portfolio company Encoded Therapeutics. Read More

UK earnings, trading statements calendar - next 7 days

7th Sep 2026 11:27

UK earnings, trading statements calendar - next 7 days

3rd Sep 2026 14:24

IN BRIEF: RTW Biotech Opportunities get 0.2% uplift from Alesta deal

19th Aug 2026 12:40

RTW Biotech Opportunities Ltd - investor in life sciences sector - Notes the announcement by BioMarin Pharmaceuticals Inc that it has agreed to buy RTW Biotech portfolio holding Alesta Therapeutics, which will give net asset value a boost. BioMarin will pay USD275 million upfront in cash for Alesta's lead asset, ALE1, which RTW says represents a 41% uplift on its own carrying value for Alesta. This will result in a USD1.6 million, or 0.2%, addition to RTW Biotech's net asset value as of July 31. Read More

RTW Biotech's Avere to go public in US in reverse merger with NextCure

12th Aug 2026 09:38

(Alliance News) - RTW Biotech Opportunities Ltd on Wednesday noted that portfolio holding Avere Therapeutics will go public via a reverse merger with Nasdaq-listed NextCure Inc. Read More

RTW Biotech investee Obsidian debuts on Nasdaq after Galera deal

5th Aug 2026 14:00

(Alliance News) - RTW Biotech Opportunities Ltd on Wednesday noted its investee Obsidian Therapeutics Inc has gone public on the Nasdaq in New York following a reverse merger with Galera Therapeutics Inc. Read More

EARNINGS AND TRADING: Hargreaves Services results beat guidance

29th Jul 2026 17:51

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More

RTW Biotech invests USD1.4 million in Lycia Therapeutics' series D

26th Jun 2026 09:51

(Alliance News) - RTW Biotech Opportunities Ltd on Friday said it has made an additional investment in portfolio company Lycia Therapeutics Inc as part of its series D financing round. Read More

WINNERS & LOSERS: Oil majors fall, airlines up on US-Iran peace hopes

12th Jun 2026 10:36

(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Friday. Read More

UK shareholder meetings calendar - next 7 days

4th Jun 2026 12:27

IN BRIEF: RTW Biotech makes additional investment in Windward Bio

8th May 2026 10:59

RTW Biotech Opportunities Ltd - Guernsey-based investor in the life sciences sector - Invests USD1.7 million as part of portfolio company Windward Bio's USD165 million crossover financing. RTW Biotech says it first invested in the private, clinical-stage biotechnology company as part of its series A round back in January of last year. Notes that Windward Bio is focused on improving outcomes for people living with serious immunological diseases, with its lead programme WIN378 an antibody designed to treat asthma and chronic obstructive pulmonary disease. Read More

WINNERS & LOSERS: Intertek in red after latest EQT rejection

8th May 2026 10:46

(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Friday. Read More

RTW Biotech gets net asset value lift from IPO of Kailera Therapeutics

20th Apr 2026 10:32

(Alliance News) - RTW Biotech Opportunities Ltd on Monday noted that US portfolio company Kailera Therapeutics Inc raised a record USD625 million in its upsized initial public offering in New York. Read More

RTW Biotech rises as cancer therapy firm agrees to reverse merger

15th Apr 2026 11:22

(Alliance News) - RTW Biotech Opportunities on Wednesday welcomed news of a reverse merger between its portfolio company Obsidian Therapeutics Inc and Galera Therapeutics Inc. Read More

Apellis investors respond to USD5.60 billion Biogen acquisition

1st Apr 2026 16:17

(Alliance News) - Biotech Growth Trust PLC, International Biotechnology Trust PLC, ad RTW Biotech Opportunities Ltd have all noted the agreement announced by Biogen Inc on Tuesday to acquire Apellis Pharmaceuticals, Inc. Read More

RTW Biotech net asset value grows healthily in 2025; outlook positive

30th Mar 2026 10:17

(Alliance News) - RTW Biotech Opportunities Ltd on Monday said it is "cautiously optimistic" looking ahead as it reported a sharply higher net asset value per share. Read More

LONDON BRIEFING: Stocks down, boohoo "comfortably ahead" of guidance

30th Mar 2026 07:57

(Alliance News) - London stocks were called to open lower on Monday, as the Iran war continues, while in UK company news, Burford Capital called a US appeals court decision on Argentina's nationalisation of oil company YPF in 2012 "very disappointing". Read More

WINNERS & LOSERS: Metlen Energy takes hit from annual results delay

27th Mar 2026 10:30

(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Friday. Read More

UK earnings, trading statements calendar - next 7 days

23rd Mar 2026 16:25

FTSE 100 Latest

Value10,708.33

Change0.00